Clinical Trial: Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Ewing Sarcoma
Study Type: INTERVENTIONAL
Official Title: A Phase I Trial of Cabozantinib (XL184) in Combination With High-dose Ifosfamide in Adults and Children With Relapsed/Refractory Ewing Sarcoma and Osteosarcoma
Brief Summary:
The purpose of this study is to better understand how safe and effective the drug cabozantinib in combination with high-dose ifosfamide is in the treatment of children and adults with relapsed/refractory Ewing sarcoma and osteosarcoma.
Read more